These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22873214)

  • 1. Role of acyclic retinoid in the chemoprevention of hepatocellular carcinoma: basic aspects, clinical applications, and future prospects.
    Shimizu M; Imai K; Takai K; Moriwaki H
    Curr Cancer Drug Targets; 2012 Nov; 12(9):1119-28. PubMed ID: 22873214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids.
    Shimizu M; Shirakami Y; Hanai T; Imai K; Suetsugu A; Takai K; Shiraki M; Moriwaki H
    Mol Nutr Food Res; 2014 Jan; 58(1):124-35. PubMed ID: 24273224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention of hepatocellular carcinoma by acyclic retinoid.
    Shimizu M; Sakai H; Moriwaki H
    Front Biosci (Landmark Ed); 2011 Jan; 16(2):759-69. PubMed ID: 21196201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclic retinoid in the chemoprevention of hepatocellular carcinoma (review).
    Kojima S; Okuno M; Matsushima-Nishiwaki R; Friedman SL; Moriwaki H
    Int J Oncol; 2004 Apr; 24(4):797-805. PubMed ID: 15010815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyclic retinoid in chemoprevention of hepatocellular carcinoma: Targeting phosphorylated retinoid X receptor-α for prevention of liver carcinogenesis.
    Shimizu M; Shirakami Y; Imai K; Takai K; Moriwaki H
    J Carcinog; 2012; 11():11. PubMed ID: 23230390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention.
    Shimizu M; Takai K; Moriwaki H
    Cancer Sci; 2009 Mar; 100(3):369-74. PubMed ID: 19068086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid.
    Matsushima-Nishiwaki R; Okuno M; Takano Y; Kojima S; Friedman SL; Moriwaki H
    Carcinogenesis; 2003 Aug; 24(8):1353-9. PubMed ID: 12807734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acyclic retinoid inhibits diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BLKS/J- +(db)/+Lepr(db) mice.
    Shimizu M; Sakai H; Shirakami Y; Iwasa J; Yasuda Y; Kubota M; Takai K; Tsurumi H; Tanaka T; Moriwaki H
    Cancer Prev Res (Phila); 2011 Jan; 4(1):128-36. PubMed ID: 21071580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic growth inhibition by acyclic retinoid and vitamin K2 in human hepatocellular carcinoma cells.
    Kanamori T; Shimizu M; Okuno M; Matsushima-Nishiwaki R; Tsurumi H; Kojima S; Moriwaki H
    Cancer Sci; 2007 Mar; 98(3):431-7. PubMed ID: 17270033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis induction by acyclic retinoid: a molecular basis of 'clonal deletion' therapy for hepatocellular carcinoma.
    Okuno M; Sano T; Matsushima-Nishiwaki R; Adachi S; Akita K; Okano Y; Kojima S; Moriwaki H
    Jpn J Clin Oncol; 2001 Aug; 31(8):359-62. PubMed ID: 11574627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyclic retinoid synergises with valproic acid to inhibit growth in human hepatocellular carcinoma cells.
    Tatebe H; Shimizu M; Shirakami Y; Sakai H; Yasuda Y; Tsurumi H; Moriwaki H
    Cancer Lett; 2009 Nov; 285(2):210-7. PubMed ID: 19520494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. Updated analysis of the long-term follow-up data.
    Takai K; Okuno M; Yasuda I; Matsushima-Nishiwaki R; Uematsu T; Tsurumi H; Shiratori Y; Muto Y; Moriwaki H
    Intervirology; 2005; 48(1):39-45. PubMed ID: 15785088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of serum lectin-reactive alpha-fetoprotein by acyclic retinoid: a potent biomarker in the chemoprevention of second primary hepatoma.
    Moriwaki H; Yasuda I; Shiratori Y; Uematsu T; Okuno M; Muto Y
    Clin Cancer Res; 1997 May; 3(5):727-31. PubMed ID: 9815742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
    Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
    Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of hepatocellular carcinoma: concept, progress and perspectives.
    Okuno M; Kojima S; Moriwaki H
    J Gastroenterol Hepatol; 2001 Dec; 16(12):1329-35. PubMed ID: 11851828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic growth inhibition by 9-cis-retinoic acid plus trastuzumab in human hepatocellular carcinoma cells.
    Tatebe H; Shimizu M; Shirakami Y; Tsurumi H; Moriwaki H
    Clin Cancer Res; 2008 May; 14(9):2806-12. PubMed ID: 18451248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of retinoid X receptor alpha at serine 260 impairs its metabolism and function in human hepatocellular carcinoma.
    Matsushima-Nishiwaki R; Okuno M; Adachi S; Sano T; Akita K; Moriwaki H; Friedman SL; Kojima S
    Cancer Res; 2001 Oct; 61(20):7675-82. PubMed ID: 11606411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic growth inhibition by acyclic retinoid and phosphatidylinositol 3-kinase inhibitor in human hepatoma cells.
    Baba A; Shimizu M; Ohno T; Shirakami Y; Kubota M; Kochi T; Terakura D; Tsurumi H; Moriwaki H
    BMC Cancer; 2013 Oct; 13():465. PubMed ID: 24103747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic growth inhibition of human hepatocellular carcinoma cells by acyclic retinoid and GW4064, a farnesoid X receptor ligand.
    Ohno T; Shirakami Y; Shimizu M; Kubota M; Sakai H; Yasuda Y; Kochi T; Tsurumi H; Moriwaki H
    Cancer Lett; 2012 Oct; 323(2):215-22. PubMed ID: 22579649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acyclic retinoid inhibits human hepatoma cell growth by suppressing fibroblast growth factor-mediated signaling pathways.
    Shao RX; Otsuka M; Kato N; Taniguchi H; Hoshida Y; Moriyama M; Kawabe T; Omata M
    Gastroenterology; 2005 Jan; 128(1):86-95. PubMed ID: 15633126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.